{"SPADE_UN_26577": {"Sequence Information": {"Peptide Name": "Temporin-SHa [G10K]", "Sequence": "FLSGIVGMLKKLF", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "B3KYH4", "uniprotUrl": "http://www.uniprot.org/uniprot/B3KYH4", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Synthesis of Second-Generation Analogs of Temporin-SHa Peptide Having Broad-Spectrum Antibacterial and Anticancer Effects", "Pubmed ID": "39200058", "Reference": "Antibiotics (Basel). 2024;13:758", "Author": "Khan AI, Nazir S, Haque MNU, Maharjan R, Khan FA, Olleik H, Courvoisier-Dezord E, Maresca M, Shaheen F", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39200058"}], "Mass": 1452.84, "PI": 10.0, "Net Charge": 2, "Hydrophobicity": 1.4, "Frequent Amino Acids": "LFG", "Absent Amino Acids": "ACDEHNOPQRTUWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 5, "Positive Residues": 2, "Negative Residues": 0, "SPADE ID": "SPADE_UN_26577", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_26577", "Similarity": 1.0, "Sequence": "FLSGIVGMLKKLF"}, {"SPADE_ID": "SPADE_N_06421", "Similarity": 1.0, "Sequence": "KKLFKKILKYLKK"}, {"SPADE_ID": "SPADE_N_06422", "Similarity": 1.0, "Sequence": "KKLFKKILKYLKKL"}], "Hemolytic Activity": "Human bronchial epithelial cells BEAS-2B:IC50=74.8±7.4 µM,Human Lung Fibroblasts IMR-90:IC50=>100 µM", "Target Organism": "Acinetobacter baumannii DSM 30007(MIC=3.12µM),Enterobacter cloacae DSM 30054(MIC=12.5µM),Escherichia coli ATCC 8739(MIC=25µM),Helicobacter pylori ATCC 43504(MIC=3.12µM),Klebsiella pneumoniae DSM 26371(MIC=25µM),Pseudomonas aeruginosa ATCC 9027(MIC=25µM),Bacillus subtilis ATCC 6633(MIC=3.12µM),Enterococcus faecalis DSM 2570(MIC=6.25µM),Enterococcus faecium DSM 20477(MIC=6.25µM),Staphylococcus aureus ATCC 6538(MIC=3.12µM),Human breast adenocarcinoma MCF-7(IC50=37.4±11.8µM),Human hepatocellular carcinoma HepG2(IC50=64.3±3.5µM),Human ovarian adenocarcinoma A2780(IC50=21.8±3.2µM),Human pancreatic carcinoma Mia PaCa-2(IC50=61.4±4.1µM),Human prostate adenocarcinoma PC-3(IC50=11.7±1.2µM),Human skin melanoma MNT-1(IC50=21.7±6.9µM),Human lung carcinoma A549(IC50=32.6±2.4µM)"}}}